Overview
State Action
Filter by Key Issue, Year, or Status
No items found
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Filter by Key Issue
No items found
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Filter by Key Issue
Haller v. U.S. Department of Health and Human Services – Federal
District Court: Eastern District of New York Status: Decided
The complaint alleges that major parts of the No Surprises Act are unconstitutional. Specifically, Dr. Haller claims that the federal IDR process and prohibition of …
LifeNet v. U.S. Department of Health and Human Services – Federal
District Court: Eastern District of Texas Status: Decided
LifeNet, an air ambulance provider based in Texas that transports patients in Louisiana and Arkansas, filed suit to challenge the No Surprises Act, claiming the government treats …
American Academy Of Emergency Medicine Physician Group, Inc. v. Envision Healthcare Corporation et al. – Federal
District Court: Northern District of California Status: Pending
In December 2021, American Academy of Emergency Medicine Physician Group (AAEM-PG), a professional medical association of emergency medicine physicians, filed suit against Envision Healthcare, a …
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the …
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase …